After Robert Kadlec was confirmed as President Trump’s top official for
public health preparedness in 2017, he began pressing to increase
government stocks of a smallpox vaccine. His office ultimately made a
deal to buy up to $2.8 billion of the vaccine from a company that once
paid Kadlec as a consultant, a connection he did not disclose on a
Senate questionnaire when he was nominated.
Publisher: Washington Post | Author: Jon Swaine